Sleep Quality Improvement Enhances Neuropsychological Recovery and Reduces Blood Aβ<sub>42/40</sub> Ratio in Patients with Mild–Moderate Cognitive Impairment
<i>Background and objectives</i>: Alzheimer’s disease is a progressive brain degeneration and is associated with a high prevalence of sleep disorders. Amyloid β peptide-42/40 (Aβ<sub>42/40</sub>) and Tau-pT181 are the core biomarkers in cerebrospinal fluid and blood. Accumula...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/57/12/1366 |